Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Transaction in Own Shares

BlackRock Sustainable American Income Trust plc (‘the Company’)LEI – 549300WWOCXSC241W468Transaction in own shares: purchase of own shares to be held in treasuryThe Company announces that it has today purchased 20,000 of its Ordinary Shares at an average price of 196.5 pence per share to be held in treasury.Following settlement of this purchase on 26 April 2024 the issued share capital of the Company will be 77,264,676 Ordinary Shares, excluding 23,096,629 shares which are held in treasury. Shares held in treasury do not carry any voting rights; 23.01% of the Company’s total issued

Report from Atlas Copco’s Annual General Meeting 2024

Nacka, Sweden, April 24, 2024: Atlas Copco AB on Wednesday April 24 held its Annual General Meeting, chaired by Hans Stråberg, Chair of the Board of Directors.The income statements and the balance sheets of the parent company and the Group were approved, together with the Board’s proposal for profit distribution. The Board of Directors and the President & CEO were discharged from liability for the financial year 2023. The proposed dividend of SEK 2.80 per share is to be paid in two instalments. The first instalment amount will be SEK 1.40 and the second instalment amount will be SEK 1.40.

The Board of Directors of NextCell resolves on a rights issue of units of approximately SEK 40.1 million, subject to approval by an Extraordinary General Meeting

THIS PRESS RELEASE MAY NOT BE RELEASED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND, CANADA, HONG KONG, BELARUS, RUSSIA OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLISHING OR DISTRIBUTION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTATION OR OTHER MEASURES IN ADDITION TO THOSE REQUIRED BY SWEDISH LAW. SEE SECTION ”IMPORTANT INFORMATION” AT THE END OF THIS PRESS RELEASE. The Board of Directors of NextCell Pharma AB (publ) (”NextCell” or the ”Company”) has

Dignitana’s CEO Catarina Mård Löwenadler resigns – Fredrik Jonsson appointed as new CEO

Dignitana AB announces today that Catarina Mård Löwenadler, CEO of Dignitana, after consulting with the Board of Directors, will resign as CEO on 2 May 2024, and that Fredrik Jonsson will assume the position as new CEO on the same day. To ensure a smooth transition, Catarina Mård Löwenadler will remain at Dignitana for a period after Fredrik Jonsson has assumed the position of CEO of the Company.   “On behalf of the Board, I would like to thank Catarina for the good work she has done at Dignitana. Among other things, she has been a valuable contributor to the development of Dignitana’

Wihlborgs Fastigheter AB (publ) AGM 2024

At Wihlborgs Fastigheter AB’s AGM on 24 April 2024, the meeting agreed to the Board’s proposal for a dividend for 2023 of SEK 3.15 per share. The record date for receiving the dividend was set at Friday, 26 April 2024. Cash payment will be sent by Euroclear Sweden AB on Thursday 2 May 2024. The Board of Directors and the CEO were granted freedom of responsibility for the year 2023. The AGM agreed that the Board be authorized until no later than the next Annual General Meeting to acquire and assign own shares. An acquisition shall not exceed the number of shares which from time to time

Alligo strengthens its position in Finland - acquires Hämeen Teollisuuspalvelu Oy and Riihimäen Teollisuuspalvelu Oy

Alligo has entered into an agreement to acquire 100 percent of the shares in the Finnish companies Hämeen Teollisuuspalvelu Oy and Riihimäen Teollisuuspalvelu Oy. The companies operate in several locations in southern Finland and sell tools, supplies, industrial components, workwear and personal protection.The companies have a combined annual turnover of approximately EUR 15 million and 42 employees. They have a total of five stores in Hämeenlinna, Riihimäki, Tampere and Hyvinkää. -        With Alligo as an owner, we feel strengthened in our efforts to continue developing our businesses.

Pihlajalinna Oyj: Acquisition of own shares on April 24, 2024

Pihlajalinna Oyj: Acquisition of own shares on April 24, 2024 Pihlajalinna Oyj’s stock exchange release on April 24, 2024, at 07:00 p.m. EET Date April 24, 2024Exchange transaction BuyShare trading code PIHLISAmount, shares 606Average price/share (EUR) 7.8147Total cost (EUR) 4,735.71 After the acquisitions Pihlajalinna Oyj holds a total of 80,790 treasury shares. ON BEHALF OF PIHLAJALINNA OYJ Danske Bank A/S, Finland Branch  Antti Väliaho                        Jonathan Nyberg Additional Information

Attendo to buy back shares for a maximum amount of SEK 110 million

Attendo’s Board of Directors has decided to utilize the authorization by the 2024 AGM to acquire own shares in order to adjust the company’s capital structure.The share buyback programme will be carried out in accordance with the EU Market Abuse Regulation (MAR) and Commission Delegated Regulation (EU) 2016/1052 (the so-called Safe Harbour Regulation). Acquisitions of shares will be managed by Skandinaviska Enskilda Banken AB. The share buyback programme is subject to the following terms: · Buybacks are to take place on Nasdaq Stockholm in accordance with its Rule Book for Issuers,

Redsense Medical welcomes new investment from ShapeQ to accelerate growth

Today Redsense Medical has announced a direct share issue to ShapeQ and the press release can be found at https://redsensemedical.com/investors-media/press-releases/. This direct share issue to ShapeQ, one of our current main investors, means that Redsense Medical will receive approximately MSEK 9.8 before deduction of costs related to the issue. It should be noted that subscription price exceeded the current market value. "The investment from ShapeQ is a clear sign of trust and commitment to drive Redsense towards a successful future. It is important to note that this investment is

Bulletin from Attendo's Annual General Meeting 2024

Attendo AB (publ) held its Annual General Meeting on 24 April 2024. The meeting resolved in accordance with all proposals by the Board of Directors and Nomination Committee.Election of Board of Directors and auditor The Annual General Meeting resolved that the number of Board members shall be seven and re-elected the Board members Ulf Mattsson, Catarina Fagerholm, Tobias Lönnevall, Suvi-Anne Siimes, Nora F. Larssen, Per Josefsson and Antti Ylikorkala. Ulf Mattsson was re-elected as Chair of the Board of Directors. The Annual General Meeting resolved that the company shall have a

Lea bank ASA - Resolution to increase the share capital, related to share options program

The Board of Directors of Lea Bank ASA has on 24 April 2024 resolved to increase the share capital in connection with exercise of options granted under the company’s share options program from 2020. Strike was NOK 7 per share, minus dividends during the program. The capital increase will be made as a private placement of 230 000 shares with a nominal value of NOK 2.00 at a price of NOK 5,04 per share. As a result, the share capital will be increased by NOK 460 000 to NOK 190 898 264. The number of shares after the issue will be 95 449 132. Contact: Oddbjørn Berentsen, CEO

Lea bank ASA – Exercise of stock options

Lea bank has received notice of exercise of options from Primary insiders of options granted under the company’s share options program from 2020. The Board of Directors of Lea Bank ASA has on 24 April 2024 resolved to fulfil the bank’s commitment with a cash settlement. The cash settlement was based on the volume weighted average 10 days prior to notice of exercise, minus strike of NOK 7 per share, minus dividends during the program. CFO Gard Haugen exercised all his 230 000 options CCRO Christian Svendsen exercised all his 330 000 options CCO/CRO Geir Jørgensen exercised all his

Nanoform announces its intention to carry out a new share issue of approximately 7 million new shares to invest in commercialization of nanoparticle enabled formulations for next generation medicines

Inside information Nanoform Finland Plc April 24, 2024 18.31 Finnish time / 17.31 Swedish time NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, NEW ZEALAND, AUSTRALIA, JAPAN, HONG KONG, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Nanoform announces its intention to carry out a new share issue of approximately 7 million new shares to invest in commercialization of nanoparticle enabled formulations for next generation medicines · New share issue of

UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 24.04.2024

United Bankers Plc NOTIFICATION   24.04.2024 at 18:30   UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 24.04.2024   Date 24.04.2024  Exchange transaction Buy  Share class UNITED  Amount 160  Average price/share 16.6028 EURHighest price/share 16.6500 EURLowest price/share 16.6000 EURTotal price 2,656.45  EUR        The shares held by United Bankers Plc on 24.04.2024   UNITED 5,319         On behalf of United

Vår Energi ASA: Shares allocated to primary insiders as part of the long-term incentive program

Sandnes, Norway, 24 April 2024: As part of Vår Energi ASA’s (OSE: VAR) long-term incentive (LTI) program for executive committee, a total number of 520 807 shares at an average price of 36.3278 NOK per share have been allocated. Under the program, the executive committee can be awarded between 12.5% to 45% of their base salary in restricted shares. The CEO can be awarded between 50% to 100% of his base salary. The restricted shares have a vesting period of three years. Details on individual allocation of shares to primary insiders is included in the attached notification of trading.

DNB Markets – Episurf Medical: New US distributor agreement

Episurf Medical reported Q1 earnings (loss) broadly in line with our expectation, despite somewhat lower sales. While it seems to have lost some short-term momentum on a shift from own sales to more distributors, we expect a recovery in the coming quarters. The company signed another US distribution agreement after quarter-end and we expect more to come over time. We have adjusted our fair value to SEK0.75–2.25 (1.5–4.5) for the announced rights issue.Earnings improving but not as fast as expected. Q1 sales were SEK3.1m, versus our estimate of cSEK3.9m, and the operating loss was cSEK20.6m,

#24-146 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#24-145 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

The Board of Directors in Redsense Medical AB (publ) resolves to carry out a directed share issue of approximately MSEK 9,8.

The Board of Directors in Redsense Medical AB (publ) ("Redsense" or the "Company") announces today that the Company’s Board of Directors, with the support from the authorization from the Annual General Meeting of 2023, has resolved on a directed cash issue of a maximum of 1,404,081 shares to ShapeQ GmbH at a subscription price of SEK 7 per share (the “Directed Issue”) Through the Directed Issue, the Company will receive a maximum of approximately MSEK 9,8, before deduction of costs related to the issue.The Board of Directors has resolved that the Directed Issue of a maximum of 1,404,081

Resolutions at ASSA ABLOY AB’s Annual General Meeting 24 April 2024

The Annual General Meeting of ASSA ABLOY AB was held on Wednesday 24 April 2024 in Stockholm, Sweden. Adoption of income statements and balance sheets and discharge from liability The Annual General Meeting adopted the parent company’s and the Group’s income statements and balance sheets for the financial year 2023. The members of the Board of Directors and the CEO were discharged from liability for the financial year 2023. Dividend  The Annual General Meeting approved the dividend of SEK 5.40 per share proposed by the Board of Directors, to be paid out in two equal installments,

Fayes Investeringar 1 AB publishes supplement to the offer document for the recommended public cash offer to the shareholders of Awardit AB (publ)

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of shareholders in Australia, Hong Kong, Japan, Canada, New Zealand, South Africa or the United States of America (the “US”), or any other jurisdiction in which the making of the Offer, the distribution of this press release or the acceptance of any tender of shares would contravene applicable laws or regulations or require further offer documents, filings or other measures in addition to those required under Swedish law or

There are no items matching the current filter
There are no more items matching the current filter
Back to top